 WOODCLIFF LAKE, N.J.--BUSINESS WIRE--Eagle Pharmaceuticals, Inc. Nasdaq: EGRX Eagle or the Company today announced that the U.S. Patent and Trademark Office has granted the Company U.S. Patent No. 11,103,483, entitled Formulations of Bendamustine. Eagle is submitting the 483 patent for listing in the U.S. Food and Drug Administrations Orange Book for both BENDEKA and BELRAPZO. Eagle had asserted several Orange Book-listed patents against Slayback Pharma LLC, Apotex Inc. et al, M 